Survival of motoneurons following axotomy is enhanced by lactation or by progesterone treatment

doi:10.1016/0006-8993(89)90075-9

Brain Research

Volume 491, Issue 2, 10 July 1989, Pages 379-382

https://doi.org/10.1016/0006-8993(89)90075-9 Get rights and content

Abstract

It was shown previously that neuron loss induced by nerve transection in the hypoglossal and facial motor nuclei of female rats could be reduced by long-term testosterone treatment following axotomy. In the present study, it is reported that such neuron loss could also be attenuated by lactation-related hormones and by progesterone treatment following axotomy.

Reference (21)

OdomaS. et al.
Evidence for association between blood prolactin and androgen receptors in BPH
J. Urol.
(1985)
WarembourgM. et al.
Immunocytochemical localization of progesterone receptor in the guinea pig central nervous system
Brain Research
(1986)
YuW.H.A.
Sex difference in neuronal loss induced by axotomy in the rat brain stem motor nuclei
Exp. Neurol.
(1988)
BaranaoJ.L.S. et al.
Effects of prolactin on prostate androgen receptors in male rats
J. Androl.
(1982)
DohlerK.D. et al.
Changes with age in levels of serum gonadotropins, prolactin, and gonadal steroids in prepubertal male and female rats
Endocrinology
(1975)
GiboriG. et al.
Ovarian and serum concentrations of androgen throughout pregnancy in the rat
Biol. Reprod.
(1979)
GiboriG. et al.
Sites of androgen and estradiol production in the second half of pregnancy in the rat
Biol. Reprod.
(1981)
GrosvenorC.E. et al.
Comparison of plasma profiles of oxytocin and prolactin following suckling in the rat
Neuroendocrinology
(1986)
HollandJ.M. et al.
Effects of pituitary grafts on testosterone stimulated growth of rat prostate
Biol. Reprod.
(1980)
KatoJ. et al.
Specific progesterone receptors in the hypothalamus and anterior hypophysis of the rat
Endocrinology
(1977)

There are more references available in the full text version of this article.

Cited by (55)

5β-reduced neuroactive steroids as modulators of growth and viability of postnatal neurons and glia
2024, Journal of Steroid Biochemistry and Molecular Biology
Endogenous neurosteroids (NS) and their synthetic analogs, neuroactive steroids (NAS), are potentially useful drug-like compounds affecting the pathophysiology of miscellaneous central nervous system disorders (e.g. Alzheimer´s disease, epilepsy, depression, etc.). Additionally, NS have been shown to promote neuron viability and neurite outgrowth upon injury. The molecular, structural and physicochemical basis of the NS effect on neurons is so far not fully understood, and the development of new, biologically relevant assays is essential for their comparative analysis and for assessment of their mechanism of action. Here, we report the development of a novel, plate-based, high-content in vitro assay for screening of NS and newly synthesized, 5β-reduced NAS for the promotion of postnatal neuron survival and neurite growth using fluorescent, postnatal mixed cortical neuron cultures isolated from thy1-YFP transgenic mice. The screen allows a detailed time course analysis of different parameters, such as the number of neurons or neurite lengths of 7-day, in vitro neuron cultures. Using the screen, we identify a new NAS, compound 42, that promotes the survival and growth of postnatal neurons significantly better than several endogenous NS (dehydroepiandrosterone, progesterone, and allopregnanolone). Interestingly, we demonstrate that compound 42 also promotes the proliferation of glia (in particular oligodendrocytes) and that the glial function is critical for its neuron growth support. Computational analysis of the biological data and calculated physicochemical properties of tested NS and NAS demonstrated that their biological activity is proportional to their lipophilicity. Together, the screen proves useful for the selection of neuron-active NAS and the comparative evaluation of their biologically relevant structural and physicochemical features.
Sex differences in steroid levels and steroidogenesis in the nervous system: Physiopathological role
2020, Frontiers in Neuroendocrinology
Citation Excerpt :
An extensive literature showing protective effects of neuroactive steroids in several experimental models of CNS and PNS pathologies is available. Indeed, 17β-E and PROG are protective in experimental models of AD (Pike et al., 2009; Wang et al., 2008), PD (Bourque et al., 2009; Callier et al., 2001; Rodriguez-Perez et al., 2013), Huntington’s disease (Kumar et al., 2014; Tunez et al., 2006), epilepsy (Frye et al., 2009; Frye and Scalise, 2000; Veliskova, 2006), excitotoxicity (Azcoitia et al., 1999; Ciriza et al., 2006), stroke (Sayeed et al., 2007; Sohrabji, 2015), motoneuron degeneration (Gonzalez Deniselle et al., 2002; Huppenbauer et al., 2005; Platania et al., 2005; Yu, 1989), MS and demyelination (Garay et al., 2007; Garay et al., 2010; Ibanez et al., 2003; Spence and Voskuhl, 2012; Taylor et al., 2010), TBI (Cutler et al., 2007; Day et al., 2013; Djebaili et al., 2005; Lopez Rodriguez et al., 2011) and spinal cord injury (Elkabes and Nicot, 2014; Labombarda et al., 2006a; Mosquera et al., 2014; Siriphorn et al., 2012), among others. An important target of the neuroprotective effects of PROG is the myelin compartment.
The nervous system, in addition to be a target for steroid hormones, is the source of a variety of neuroactive steroids, which are synthesized and metabolized by neurons and glial cells. Recent evidence indicates that the expression of neurosteroidogenic proteins and enzymes and the levels of neuroactive steroids are different in the nervous system of males and females. We here summarized the state of the art of neuroactive steroids, particularly taking in consideration sex differences occurring in the synthesis and levels of these molecules. In addition, we discuss the consequences of sex differences in neurosteroidogenesis for the function of the nervous system under healthy and pathological conditions and the implications of neuroactive steroids and neurosteroidogenesis for the development of sex-specific therapeutic interventions.
Neurosteroids and neuropathic pain management: Basic evidence and therapeutic perspectives
2019, Frontiers in Neuroendocrinology
Complex mechanisms involved in neuropathic pain that represents a major health concern make its management complicated. Because neurosteroids are bioactive steroids endogenously synthesized in the nervous system, including in pain pathways, they appear relevant to develop effective treatments against neuropathic pain. Neurosteroids act in paracrine or autocrine manner through genomic mechanisms and/or via membrane receptors of neurotransmitters that pivotally modulate pain sensation. Basic studies which uncovered a direct link between neuropathic pain symptoms and endogenous neurosteroid production/regulation, paved the way for the investigations of neurosteroid therapeutic potential against pathological pain. Concordantly, antinociceptive properties of synthetic neurosteroids were evidenced in humans and animals. Neurosteroids promote peripheral analgesia mediated by T-type calcium and gamma-aminobutyric acid type A channels, counteract chemotherapy-induced neuropathic pain and ameliorate neuropathic symptoms of injured spinal cord animals by stimulating anti-inflammatory, remyelinating and neuroprotective processes. Together, these data open interesting perspectives for neurosteroid-based strategies to manage/alleviate efficiently neuropathic pain.
Neuroactive steroids, neurosteroidogenesis and sex
2019, Progress in Neurobiology
The nervous system is a target and a source of steroids. Neuroactive steroids are steroids that target neurons and glial cells. They include hormonal steroids originated in the peripheral glands, steroids locally synthesized by the neurons and glial cells (neurosteroids) and synthetic steroids, some of them used in clinical practice. Here we review the mechanisms of synthesis, metabolism and action of neuroactive steroids, including the role of epigenetic modifications and the mitochondria in their sex specific actions. We examine sex differences in neuroactive steroid levels under physiological conditions and their role in the establishment of sex dimorphic structures in the nervous system and sex differences in its function. In addition, particular attention is paid to neuroactive steroids under pathological conditions, analyzing how pathology alters their levels and their role as neuroprotective factors, considering the influence of sex in both cases.
Levels and actions of neuroactive steroids in the nervous system under physiological and pathological conditions: Sex-specific features
2016, Neuroscience and Biobehavioral Reviews
Neuroactive steroids regulate the physiology of the central and peripheral nervous system, exert neuroprotective actions and represent interesting tools for therapeutic strategies against neurodegenerative and psychiatric disorders. Sex differences in their levels are detected not only under physiological conditions but are also modified in a sex-dependent way in different pathological alterations such as Alzheimer's disease, Parkinson's disease, Huntington's disease, multiple sclerosis, traumatic brain injury, spinal cord injury, stroke, diabetic encephalopathy, psychiatric disorders and peripheral neuropathy. Interestingly, many of these disorders show sex differences in their incidence, symptomatology and/or neurodegenerative outcome. The neuroprotective actions of neuroactive steroids, together with the sex specific regulation of its levels might provide the basis to design sex-specific neuroprotective therapies. Indeed, some experiments here discussed suggest the viability of this approach.
Levels and actions of progesterone and its metabolites in the nervous system during physiological and pathological conditions
2014, Progress in Neurobiology
Progesterone is synthesized and actively metabolized in the central and peripheral nervous system, into neuroactive steroid metabolites, such as dihydroprogesterone, allopregnanolone and isopregnanolone. Progesterone and/or its metabolites exert a variety of effects acting as physiological regulators of neuronal and glial development and plasticity, controlling reproduction, neuroendocrine events, mood and affection. In addition, these neuroactive steroids maintain neural homeostasis and exert neuroprotective actions. In agreement, metabolic pathways of progesterone are affected by modifications in the level of gonadal hormones and by pathology or injury with a regional specificity and in a sex-dimorphic way. Therefore, observations here summarized may provide a background to design sex-specific therapies based on progesterone metabolites. On this point of view, considering that one of the major limits of a therapy based on neuroactive steroids could be modifications in their plasma levels and their consequent peripheral effects, pharmacological treatments aimed to increase their levels in the nervous system could provide an interesting therapeutic option.

View all citing articles on Scopus

: This work was supported by Grants 666280 and 667142 from the PSC-CUNY Research Award Program of the City University of New York and U.S. Dept. of Health & Human Services PHS Grant 2-SO7-RR07132.

^**: The author thanks Aida Lee, Greg Rudomen, and Mary Wong for cutting paraffin blocks and Barbara Cooper for typing the manuscript.

View full text

Survival of motoneurons following axotomy is enhanced by lactation or by progesterone treatment

Abstract

J. Urol.

Brain Research

Exp. Neurol.

Effects of prolactin on prostate androgen receptors in male rats

J. Androl.

Changes with age in levels of serum gonadotropins, prolactin, and gonadal steroids in prepubertal male and female rats

Endocrinology

Ovarian and serum concentrations of androgen throughout pregnancy in the rat

Biol. Reprod.

Sites of androgen and estradiol production in the second half of pregnancy in the rat

Biol. Reprod.

Comparison of plasma profiles of oxytocin and prolactin following suckling in the rat

Neuroendocrinology

Effects of pituitary grafts on testosterone stimulated growth of rat prostate

Biol. Reprod.

Specific progesterone receptors in the hypothalamus and anterior hypophysis of the rat

Endocrinology